Nirvana Life Sciences Inc

About Nirvana Life Sciences Inc

Nirvana Life Sciences is focused on developing medical products and regimens to address addiction, particularly opioid addiction. Founded with the intent to create novel therapeutic products derived from psychedelics, the company aims to offer non-addictive solutions for pain management and treatments for addiction, anxiety, and depression. Their goal is to develop psilocybin-derived medicines to break opioid addictions and provide non-addictive pain relief alternatives.

Products & Services

Initial Products:Early-stage medical products aimed at addressing addiction and pain management.

Novel Formulations:Innovative psychedelic-based formulations for therapeutic use in addiction treatment and pain relief.

Pre-Clinical Research:Research initiatives to validate the efficacy of psilocybin-based formulations in breaking addiction.

Specialties

Psychedelic-based medicines Addiction treatment Non-addictive pain management Psilocybin formulations Pre-clinical research

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Acquisition of Assets T: - FT: Acquisition of Assets	A: 800000 MR: - FA: US$800,000 FAN: 800000	D: 2022-03-24 FD: 2022-03-24	-

Acquisition of Assets Latest

2022-03-24

$800K

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Annie Storey

E

Edward Lupton

C

Chris Hoffmeister

M

Mark Marissen

B

Bruce Clark

Chief Executive Officer

C

Connie Hang

Chief Financial Officer

View 10 more team members with Pro

Unlock Full Team Directory

Recent News